Transplant Diagnostic Market Size, Segments, and Growth by Forecast by 2031

Coverage: Transplant Diagnostic Market covers analysis By Technology (Molecular Assay Technologies, Non-Molecular Assay Technologies); Product and Service (Reagents and Consumables, Instruments, Software and Services); Transplant Type (Solid Organ, Stem Cell, Soft Tissue); Application ( Diagnostic, Research), and Geography (North America, Europe, Asia Pacific, and South and Central America)

  • Report Code : TIPRE00019301
  • Category : Life Sciences
  • No. of Pages : 150
Buy Now

The Transplant Diagnostic Market is expected to register a CAGR of 8.1% from 2025 to 2031, with a market size expanding from US$ XX million in 2024 to US$ XX Million by 2031.

The report is segmented by Technology (Molecular Assay Technologies, Non-Molecular Assay Technologies). The report further presents analysis based on Product and Service (Reagents and Consumables, Instruments, Software and Services). The report is further segmented based on Transplant Type (Solid Organ, Stem Cell, Soft Tissue). Futher, it is segmented based on Application (Diagnostic, Research). The global analysis is further broken-down at regional level and major countries. The report offers the value in USD for the above analysis and segments.

Purpose of the Report

The report Transplant Diagnostic Market by The Insight Partners aims to describe the present landscape and future growth, top driving factors, challenges, and opportunities. This will provide insights to various business stakeholders, such as:

  • Technology Providers/Manufacturers: To understand the evolving market dynamics and know the potential growth opportunities, enabling them to make informed strategic decisions.
  • Investors: To conduct a comprehensive trend analysis regarding the market growth rate, market financial projections, and opportunities that exist across the value chain.
  • Regulatory bodies: To regulate policies and police activities in the market with the aim of minimizing abuse, preserving investor trust and confidence, and upholding the integrity and stability of the market.

Transplant Diagnostic Market Segmentation

Technology
  • Molecular Assay Technologies
  • Non-Molecular Assay Technologies
Product and Service
  • Reagents and Consumables
  • Instruments
  • Software and Services
Transplant Type
  • Solid Organ
  • Stem Cell
  • Soft Tissue
Application
  • Diagnostic
  • Research

Strategic Insights

Transplant Diagnostic Market Growth Drivers
  • Increasing Organ Transplants: An increase in chronic diseases and the resulting organ failure has created a boundless demand for transplant diagnostics. Advanced healthcare infrastructure and an increasing urge among people to donate organs enhance demand for effective diagnostic solutions so that transplant results can be successful.
  • Advancements in Technology: Technological changes in molecular biology and genetics also challenge technologies, such as high-throughput sequencing and real-time PCR are becoming commonplace, allowing for more accurate and efficient transplant diagnostic testing with improved matching between the donor and the recipient and transplantation rejection monitoring.
  • Increased Research Funding: Higher funding in research and development for transplant diagnostics has increased the market. Whereby the government and private sectors are offering increased funding, therefore different innovations and new assays and technologies to comparatively advance towards the better diagnosis of patients.
Transplant Diagnostic Market Future Trends
  • Personalized Medicine: The direction for personalized medicine is the trend that gives shape to the transplant diagnostic market. Diagnostic approaches are designed to account for individual genetic profiles, thus increasing the potential of successful transplantation as well as reducing unwanted reactions in patients.
  • AI integration: Artificial intelligence will be increasingly applied in transplant diagnostics; it expands data analysis and offers modeling. AI-driven tools are able to heighten the rationality of the decision-making process and can help healthcare professionals do a better estimation of their compatibility as a donor recipient. AI also can help track health status post-transplantation.
  • Expansion of Biomarker Discovery: It is also expanding the discovery of new biomarkers related to transplant rejection. Advances in this area open up continuously new diagnostic possibilities. New biomarkers can be discovered that point specifically to genetic or molecular markers, even allowing the possibility for earlier detection and monitoring of complications, thereby improving transplant outcomes.
Transplant Diagnostic Market Opportunities
  • Collaborations with Biotech Companies: Collaborations will hasten the pace of advanced diagnostics to organ transplantations. Some collaborative ventures help in the creation of new diagnostic assays and other tools in advance as developed jointly. Transplant care becomes effective as a whole.
  • Education and Training Programs: Transplant diagnostics programs about the importance of transplant diagnostics in their professional education can bring forth new avenues. The enhanced knowledge and skill set will be required to maximize the utilization of diagnostic tools with accuracy for better patient outcomes for transplant procedures.
  • Home Monitoring Solutions: There is an opportunity in the at-home health monitoring solutions for transplant diagnostic kits, which could empower the patients to monitor their health in the post-transplant period, thereby reducing pressure on healthcare facilities while making timely interventions when required.

Market Report Scope

Key Selling Points

  • Comprehensive Coverage: The report comprehensively covers the analysis of products, services, types, and end users of the Transplant Diagnostic Market, providing a holistic landscape.
  • Expert Analysis: The report is compiled based on the in-depth understanding of industry experts and analysts.
  • Up-to-date Information: The report assures business relevance due to its coverage of recent information and data trends.
  • Customization Options: This report can be customized to cater to specific client requirements and suit the business strategies aptly.

The research report on the Transplant Diagnostic Market can, therefore, help spearhead the trail of decoding and understanding the industry scenario and growth prospects. Although there can be a few valid concerns, the overall benefits of this report tend to outweigh the disadvantages.

REGIONAL FRAMEWORK
World Geography

Have a question?

Analyst

Mrinal

Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.

Analyst   Speak to Analyst
  • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
  • Request discounts available for Start-Ups & Universities
MARKET PLAYERS
  • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
  • Request discounts available for Start-Ups & Universities
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


Which are some of the major players operating in the market?

Thermo Fisher Scientific Inc., Illumina Inc., and BD are some of the major players operating in the market.

Which region accounted for the higesht CAGR in the transplant diagnostic market in 2023?

Asia Pacific region accounted for the highest CAGR in the transplant diagnostic market.

What are the key benefits of the transplant diagnostic market report?

The report provides an extensive qualitative and quantitative analysis of the current trends and future estimations of the global transplant diagnostic market from 2021 to 2031, and it also determines the prevailing opportunities.

What factors are driving the transplant diagnostic market growth?

The major factors driving the transplant diagnostic market are:

1. Increasing Organ Transplants.

2. Increased Research Funding.

Which region dominated the transplant diagnostic market in 2023?

North America region dominated the transplant diagnostic market in 2023.

What is the expected CAGR of the Transplant Diagnostic Market?

The Transplant Diagnostic Market is estimated to witness a CAGR of 8.1% from 2023 to 2031

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Transplant Diagnostic Market - By Technology
1.3.2 Transplant Diagnostic Market - By Product and Service
1.3.3 Transplant Diagnostic Market - By Transplant Type
1.3.4 Transplant Diagnostic Market - By Application
1.3.5 Transplant Diagnostic Market - By Region
1.3.5.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. TRANSPLANT DIAGNOSTIC MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. TRANSPLANT DIAGNOSTIC MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. TRANSPLANT DIAGNOSTIC MARKET - GLOBAL MARKET ANALYSIS
6.1. TRANSPLANT DIAGNOSTIC - GLOBAL MARKET OVERVIEW
6.2. TRANSPLANT DIAGNOSTIC - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE
7. TRANSPLANT DIAGNOSTIC MARKET - REVENUE AND FORECASTS TO 2028 - TECHNOLOGY
7.1. OVERVIEW
7.2. TECHNOLOGY MARKET FORECASTS AND ANALYSIS
7.3. MOLECULAR ASSAY TECHNOLOGIES
7.3.1. Overview
7.3.2. Molecular Assay Technologies Market Forecast and Analysis
7.4. NON-MOLECULAR ASSAY TECHNOLOGIES
7.4.1. Overview
7.4.2. Non-Molecular Assay Technologies Market Forecast and Analysis
8. TRANSPLANT DIAGNOSTIC MARKET - REVENUE AND FORECASTS TO 2028 - PRODUCT AND SERVICE
8.1. OVERVIEW
8.2. PRODUCT AND SERVICE MARKET FORECASTS AND ANALYSIS
8.3. REAGENTS AND CONSUMABLES
8.3.1. Overview
8.3.2. Reagents and Consumables Market Forecast and Analysis
8.4. INSTRUMENTS
8.4.1. Overview
8.4.2. Instruments Market Forecast and Analysis
8.5. SOFTWARE AND SERVICES
8.5.1. Overview
8.5.2. Software and Services Market Forecast and Analysis
9. TRANSPLANT DIAGNOSTIC MARKET - REVENUE AND FORECASTS TO 2028 - TRANSPLANT TYPE
9.1. OVERVIEW
9.2. TRANSPLANT TYPE MARKET FORECASTS AND ANALYSIS
9.3. SOLID ORGAN
9.3.1. Overview
9.3.2. Solid Organ Market Forecast and Analysis
9.4. STEM CELL
9.4.1. Overview
9.4.2. Stem Cell Market Forecast and Analysis
9.5. SOFT TISSUE
9.5.1. Overview
9.5.2. Soft Tissue Market Forecast and Analysis
10. TRANSPLANT DIAGNOSTIC MARKET - REVENUE AND FORECASTS TO 2028 - APPLICATION
10.1. OVERVIEW
10.2. APPLICATION MARKET FORECASTS AND ANALYSIS
10.3. DIAGNOSTIC
10.3.1. Overview
10.3.2. Diagnostic Market Forecast and Analysis
10.4. RESEARCH
10.4.1. Overview
10.4.2. Research Market Forecast and Analysis
11. TRANSPLANT DIAGNOSTIC MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
11.1. NORTH AMERICA
11.1.1 North America Transplant Diagnostic Market Overview
11.1.2 North America Transplant Diagnostic Market Forecasts and Analysis
11.1.3 North America Transplant Diagnostic Market Forecasts and Analysis - By Technology
11.1.4 North America Transplant Diagnostic Market Forecasts and Analysis - By Product and Service
11.1.5 North America Transplant Diagnostic Market Forecasts and Analysis - By Transplant Type
11.1.6 North America Transplant Diagnostic Market Forecasts and Analysis - By Application
11.1.7 North America Transplant Diagnostic Market Forecasts and Analysis - By Countries
11.1.7.1 United States Transplant Diagnostic Market
11.1.7.1.1 United States Transplant Diagnostic Market by Technology
11.1.7.1.2 United States Transplant Diagnostic Market by Product and Service
11.1.7.1.3 United States Transplant Diagnostic Market by Transplant Type
11.1.7.1.4 United States Transplant Diagnostic Market by Application
11.1.7.2 Canada Transplant Diagnostic Market
11.1.7.2.1 Canada Transplant Diagnostic Market by Technology
11.1.7.2.2 Canada Transplant Diagnostic Market by Product and Service
11.1.7.2.3 Canada Transplant Diagnostic Market by Transplant Type
11.1.7.2.4 Canada Transplant Diagnostic Market by Application
11.1.7.3 Mexico Transplant Diagnostic Market
11.1.7.3.1 Mexico Transplant Diagnostic Market by Technology
11.1.7.3.2 Mexico Transplant Diagnostic Market by Product and Service
11.1.7.3.3 Mexico Transplant Diagnostic Market by Transplant Type
11.1.7.3.4 Mexico Transplant Diagnostic Market by Application
11.2. EUROPE
11.2.1 Europe Transplant Diagnostic Market Overview
11.2.2 Europe Transplant Diagnostic Market Forecasts and Analysis
11.2.3 Europe Transplant Diagnostic Market Forecasts and Analysis - By Technology
11.2.4 Europe Transplant Diagnostic Market Forecasts and Analysis - By Product and Service
11.2.5 Europe Transplant Diagnostic Market Forecasts and Analysis - By Transplant Type
11.2.6 Europe Transplant Diagnostic Market Forecasts and Analysis - By Application
11.2.7 Europe Transplant Diagnostic Market Forecasts and Analysis - By Countries
11.2.7.1 Germany Transplant Diagnostic Market
11.2.7.1.1 Germany Transplant Diagnostic Market by Technology
11.2.7.1.2 Germany Transplant Diagnostic Market by Product and Service
11.2.7.1.3 Germany Transplant Diagnostic Market by Transplant Type
11.2.7.1.4 Germany Transplant Diagnostic Market by Application
11.2.7.2 France Transplant Diagnostic Market
11.2.7.2.1 France Transplant Diagnostic Market by Technology
11.2.7.2.2 France Transplant Diagnostic Market by Product and Service
11.2.7.2.3 France Transplant Diagnostic Market by Transplant Type
11.2.7.2.4 France Transplant Diagnostic Market by Application
11.2.7.3 Italy Transplant Diagnostic Market
11.2.7.3.1 Italy Transplant Diagnostic Market by Technology
11.2.7.3.2 Italy Transplant Diagnostic Market by Product and Service
11.2.7.3.3 Italy Transplant Diagnostic Market by Transplant Type
11.2.7.3.4 Italy Transplant Diagnostic Market by Application
11.2.7.4 Spain Transplant Diagnostic Market
11.2.7.4.1 Spain Transplant Diagnostic Market by Technology
11.2.7.4.2 Spain Transplant Diagnostic Market by Product and Service
11.2.7.4.3 Spain Transplant Diagnostic Market by Transplant Type
11.2.7.4.4 Spain Transplant Diagnostic Market by Application
11.2.7.5 United Kingdom Transplant Diagnostic Market
11.2.7.5.1 United Kingdom Transplant Diagnostic Market by Technology
11.2.7.5.2 United Kingdom Transplant Diagnostic Market by Product and Service
11.2.7.5.3 United Kingdom Transplant Diagnostic Market by Transplant Type
11.2.7.5.4 United Kingdom Transplant Diagnostic Market by Application
11.2.7.6 Rest of Europe Transplant Diagnostic Market
11.2.7.6.1 Rest of Europe Transplant Diagnostic Market by Technology
11.2.7.6.2 Rest of Europe Transplant Diagnostic Market by Product and Service
11.2.7.6.3 Rest of Europe Transplant Diagnostic Market by Transplant Type
11.2.7.6.4 Rest of Europe Transplant Diagnostic Market by Application
11.3. ASIA-PACIFIC
11.3.1 Asia-Pacific Transplant Diagnostic Market Overview
11.3.2 Asia-Pacific Transplant Diagnostic Market Forecasts and Analysis
11.3.3 Asia-Pacific Transplant Diagnostic Market Forecasts and Analysis - By Technology
11.3.4 Asia-Pacific Transplant Diagnostic Market Forecasts and Analysis - By Product and Service
11.3.5 Asia-Pacific Transplant Diagnostic Market Forecasts and Analysis - By Transplant Type
11.3.6 Asia-Pacific Transplant Diagnostic Market Forecasts and Analysis - By Application
11.3.7 Asia-Pacific Transplant Diagnostic Market Forecasts and Analysis - By Countries
11.3.7.1 Australia Transplant Diagnostic Market
11.3.7.1.1 Australia Transplant Diagnostic Market by Technology
11.3.7.1.2 Australia Transplant Diagnostic Market by Product and Service
11.3.7.1.3 Australia Transplant Diagnostic Market by Transplant Type
11.3.7.1.4 Australia Transplant Diagnostic Market by Application
11.3.7.2 China Transplant Diagnostic Market
11.3.7.2.1 China Transplant Diagnostic Market by Technology
11.3.7.2.2 China Transplant Diagnostic Market by Product and Service
11.3.7.2.3 China Transplant Diagnostic Market by Transplant Type
11.3.7.2.4 China Transplant Diagnostic Market by Application
11.3.7.3 India Transplant Diagnostic Market
11.3.7.3.1 India Transplant Diagnostic Market by Technology
11.3.7.3.2 India Transplant Diagnostic Market by Product and Service
11.3.7.3.3 India Transplant Diagnostic Market by Transplant Type
11.3.7.3.4 India Transplant Diagnostic Market by Application
11.3.7.4 Japan Transplant Diagnostic Market
11.3.7.4.1 Japan Transplant Diagnostic Market by Technology
11.3.7.4.2 Japan Transplant Diagnostic Market by Product and Service
11.3.7.4.3 Japan Transplant Diagnostic Market by Transplant Type
11.3.7.4.4 Japan Transplant Diagnostic Market by Application
11.3.7.5 South Korea Transplant Diagnostic Market
11.3.7.5.1 South Korea Transplant Diagnostic Market by Technology
11.3.7.5.2 South Korea Transplant Diagnostic Market by Product and Service
11.3.7.5.3 South Korea Transplant Diagnostic Market by Transplant Type
11.3.7.5.4 South Korea Transplant Diagnostic Market by Application
11.3.7.6 Rest of Asia-Pacific Transplant Diagnostic Market
11.3.7.6.1 Rest of Asia-Pacific Transplant Diagnostic Market by Technology
11.3.7.6.2 Rest of Asia-Pacific Transplant Diagnostic Market by Product and Service
11.3.7.6.3 Rest of Asia-Pacific Transplant Diagnostic Market by Transplant Type
11.3.7.6.4 Rest of Asia-Pacific Transplant Diagnostic Market by Application
11.4. MIDDLE EAST AND AFRICA
11.4.1 Middle East and Africa Transplant Diagnostic Market Overview
11.4.2 Middle East and Africa Transplant Diagnostic Market Forecasts and Analysis
11.4.3 Middle East and Africa Transplant Diagnostic Market Forecasts and Analysis - By Technology
11.4.4 Middle East and Africa Transplant Diagnostic Market Forecasts and Analysis - By Product and Service
11.4.5 Middle East and Africa Transplant Diagnostic Market Forecasts and Analysis - By Transplant Type
11.4.6 Middle East and Africa Transplant Diagnostic Market Forecasts and Analysis - By Application
11.4.7 Middle East and Africa Transplant Diagnostic Market Forecasts and Analysis - By Countries
11.4.7.1 South Africa Transplant Diagnostic Market
11.4.7.1.1 South Africa Transplant Diagnostic Market by Technology
11.4.7.1.2 South Africa Transplant Diagnostic Market by Product and Service
11.4.7.1.3 South Africa Transplant Diagnostic Market by Transplant Type
11.4.7.1.4 South Africa Transplant Diagnostic Market by Application
11.4.7.2 Saudi Arabia Transplant Diagnostic Market
11.4.7.2.1 Saudi Arabia Transplant Diagnostic Market by Technology
11.4.7.2.2 Saudi Arabia Transplant Diagnostic Market by Product and Service
11.4.7.2.3 Saudi Arabia Transplant Diagnostic Market by Transplant Type
11.4.7.2.4 Saudi Arabia Transplant Diagnostic Market by Application
11.4.7.3 U.A.E Transplant Diagnostic Market
11.4.7.3.1 U.A.E Transplant Diagnostic Market by Technology
11.4.7.3.2 U.A.E Transplant Diagnostic Market by Product and Service
11.4.7.3.3 U.A.E Transplant Diagnostic Market by Transplant Type
11.4.7.3.4 U.A.E Transplant Diagnostic Market by Application
11.4.7.4 Rest of Middle East and Africa Transplant Diagnostic Market
11.4.7.4.1 Rest of Middle East and Africa Transplant Diagnostic Market by Technology
11.4.7.4.2 Rest of Middle East and Africa Transplant Diagnostic Market by Product and Service
11.4.7.4.3 Rest of Middle East and Africa Transplant Diagnostic Market by Transplant Type
11.4.7.4.4 Rest of Middle East and Africa Transplant Diagnostic Market by Application
11.5. SOUTH AND CENTRAL AMERICA
11.5.1 South and Central America Transplant Diagnostic Market Overview
11.5.2 South and Central America Transplant Diagnostic Market Forecasts and Analysis
11.5.3 South and Central America Transplant Diagnostic Market Forecasts and Analysis - By Technology
11.5.4 South and Central America Transplant Diagnostic Market Forecasts and Analysis - By Product and Service
11.5.5 South and Central America Transplant Diagnostic Market Forecasts and Analysis - By Transplant Type
11.5.6 South and Central America Transplant Diagnostic Market Forecasts and Analysis - By Application
11.5.7 South and Central America Transplant Diagnostic Market Forecasts and Analysis - By Countries
11.5.7.1 Brazil Transplant Diagnostic Market
11.5.7.1.1 Brazil Transplant Diagnostic Market by Technology
11.5.7.1.2 Brazil Transplant Diagnostic Market by Product and Service
11.5.7.1.3 Brazil Transplant Diagnostic Market by Transplant Type
11.5.7.1.4 Brazil Transplant Diagnostic Market by Application
11.5.7.2 Argentina Transplant Diagnostic Market
11.5.7.2.1 Argentina Transplant Diagnostic Market by Technology
11.5.7.2.2 Argentina Transplant Diagnostic Market by Product and Service
11.5.7.2.3 Argentina Transplant Diagnostic Market by Transplant Type
11.5.7.2.4 Argentina Transplant Diagnostic Market by Application
11.5.7.3 Rest of South and Central America Transplant Diagnostic Market
11.5.7.3.1 Rest of South and Central America Transplant Diagnostic Market by Technology
11.5.7.3.2 Rest of South and Central America Transplant Diagnostic Market by Product and Service
11.5.7.3.3 Rest of South and Central America Transplant Diagnostic Market by Transplant Type
11.5.7.3.4 Rest of South and Central America Transplant Diagnostic Market by Application
12. IMPACT OF COVID-19 PANDEMIC ON GLOBAL TRANSPLANT DIAGNOSTIC MARKET
12.1 North America
12.2 Europe
12.3 Asia-Pacific
12.4 Middle East and Africa
12.5 South and Central America
13. INDUSTRY LANDSCAPE
13.1. MERGERS AND ACQUISITIONS
13.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
13.3. NEW PRODUCT LAUNCHES
13.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
14. TRANSPLANT DIAGNOSTIC MARKET, KEY COMPANY PROFILES
14.1. THERMO FISHER SCIENTIFIC INC.
14.1.1. Key Facts
14.1.2. Business Description
14.1.3. Products and Services
14.1.4. Financial Overview
14.1.5. SWOT Analysis
14.1.6. Key Developments
14.2. ILLUMINA INC.
14.2.1. Key Facts
14.2.2. Business Description
14.2.3. Products and Services
14.2.4. Financial Overview
14.2.5. SWOT Analysis
14.2.6. Key Developments
14.3. ABBOTT LABORATORIES
14.3.1. Key Facts
14.3.2. Business Description
14.3.3. Products and Services
14.3.4. Financial Overview
14.3.5. SWOT Analysis
14.3.6. Key Developments
14.4. BECTON, DICKINSON AND COMPANY
14.4.1. Key Facts
14.4.2. Business Description
14.4.3. Products and Services
14.4.4. Financial Overview
14.4.5. SWOT Analysis
14.4.6. Key Developments
14.5. F HOFFMAN-LA ROCHE AG
14.5.1. Key Facts
14.5.2. Business Description
14.5.3. Products and Services
14.5.4. Financial Overview
14.5.5. SWOT Analysis
14.5.6. Key Developments
14.6. HOLOGIC INC.
14.6.1. Key Facts
14.6.2. Business Description
14.6.3. Products and Services
14.6.4. Financial Overview
14.6.5. SWOT Analysis
14.6.6. Key Developments
14.7. QIAGEN NV
14.7.1. Key Facts
14.7.2. Business Description
14.7.3. Products and Services
14.7.4. Financial Overview
14.7.5. SWOT Analysis
14.7.6. Key Developments
14.8. BIOMéRIEUX SA
14.8.1. Key Facts
14.8.2. Business Description
14.8.3. Products and Services
14.8.4. Financial Overview
14.8.5. SWOT Analysis
14.8.6. Key Developments
14.9. BIO-RAD LABORATORIES INC.
14.9.1. Key Facts
14.9.2. Business Description
14.9.3. Products and Services
14.9.4. Financial Overview
14.9.5. SWOT Analysis
14.9.6. Key Developments
14.10. CAREDX
14.10.1. Key Facts
14.10.2. Business Description
14.10.3. Products and Services
14.10.4. Financial Overview
14.10.5. SWOT Analysis
14.10.6. Key Developments
15. APPENDIX
15.1. ABOUT THE INSIGHT PARTNERS
15.2. GLOSSARY OF TERMS
The List of Companies

1. Thermo Fisher Scientific Inc.
2. Illumina Inc.
3. Abbott Laboratories
4. Becton, Dickinson and Company
5. F Hoffman-La Roche AG
6. Hologic Inc.
7. Qiagen NV
8. Biomérieux SA
9. Bio-Rad Laboratories Inc.
10. CareDx

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • 3.1 Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • 3.2 Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • 3.3 Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • 3.4 Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Trends and growth analysis reports related to Life Sciences : READ MORE..